Vistagen Therapeutics Inc (VTGN)
4.785
+0.08
(+1.81%)
USD |
NASDAQ |
Apr 26, 16:00
4.785
0.00 (0.00%)
After-Hours: 20:00
Vistagen Therapeutics Total Liabilities (Quarterly): 7.783M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 7.783M |
| September 30, 2023 | 6.551M |
| June 30, 2023 | 8.183M |
| March 31, 2023 | 9.009M |
| December 31, 2022 | 9.034M |
| September 30, 2022 | 11.10M |
| June 30, 2022 | 12.67M |
| March 31, 2022 | 9.928M |
| December 31, 2021 | 10.56M |
| September 30, 2021 | 19.84M |
| June 30, 2021 | 18.29M |
| March 31, 2021 | 16.30M |
| December 31, 2020 | 15.46M |
| September 30, 2020 | 16.05M |
| June 30, 2020 | 11.78M |
| March 31, 2020 | 11.50M |
| December 31, 2019 | 11.43M |
| September 30, 2019 | 12.37M |
| June 30, 2019 | 11.32M |
| March 31, 2019 | 6.936M |
| December 31, 2018 | 5.829M |
| September 30, 2018 | 4.90M |
| June 30, 2018 | 5.034M |
| March 31, 2018 | 4.362M |
| December 31, 2017 | 3.98M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.289M |
| June 30, 2017 | 3.044M |
| March 31, 2017 | 3.096M |
| December 31, 2016 | 3.288M |
| September 30, 2016 | 2.936M |
| June 30, 2016 | 2.595M |
| March 31, 2016 | 3.967M |
| December 31, 2015 | 3.610M |
| September 30, 2015 | 3.257M |
| June 30, 2015 | 4.610M |
| March 31, 2015 | 20.81M |
| December 31, 2014 | 18.04M |
| September 30, 2014 | 17.76M |
| June 30, 2014 | 16.16M |
| March 31, 2014 | 13.06M |
| December 31, 2013 | 12.00M |
| September 30, 2013 | 13.16M |
| June 30, 2013 | 12.38M |
| March 31, 2013 | 13.44M |
| December 31, 2012 | 10.85M |
| September 30, 2012 | 6.882M |
| June 30, 2012 | 6.930M |
| March 31, 2012 | 6.047M |
| December 31, 2011 | 5.162M |
| September 30, 2011 | 9.261M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
6.551M
Minimum
Sep 2023
19.84M
Maximum
Sep 2021
12.06M
Average
11.43M
Median
Dec 2019
Total Liabilities (Quarterly) Benchmarks
| Ardelyx Inc | 130.76M |
| Axsome Therapeutics Inc | 397.26M |
| Vir Biotechnology Inc | 328.82M |
| Immuneering Corp | 12.01M |
| NovaBay Pharmaceuticals Inc | 5.72M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 131.07M |
| Shareholders Equity (Quarterly) | 123.28M |
| Current Ratio | 30.76 |
| Net Debt Paydown Yield | 0.11% |